Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


04.07.2022

1 Arch Virol
1 BMJ
3 Clin Infect Dis
1 J Gen Virol
2 J Infect
6 J Infect Dis
1 J Pediatr
2 J Virol
1 JAMA
3 MMWR Morb Mortal Wkly Rep
7 N Engl J Med
3 Pediatr Infect Dis J
7 PLoS One
1 Proc Natl Acad Sci U S A
14 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. BHANUPRAKASH V, Hosamani M, Venkatesan G, Singh RK, et al
    Long-term protective immunity to goatpox in goats after a single immunization with a live attenuated goatpox vaccine.
    Arch Virol. 2022 Jun 26. pii: 10.1007/s00705-022-05505.
    PubMed         Abstract available


    BMJ

  2. MAHASE E
    Polio: What do we know about the polioviruses detected in the UK?
    BMJ. 2022;377:o1578.
    PubMed        


    Clin Infect Dis

  3. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    PubMed         Abstract available

  4. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    PubMed         Abstract available

  5. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    PubMed         Abstract available


    J Gen Virol

  6. ELBEHAIRY MA, Samal SK, Belov GA
    Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.
    J Gen Virol. 2022;103.
    PubMed         Abstract available


    J Infect

  7. XIAO J, Zhu Q, Yang F, Zeng S, et al
    The impact of enterovirus A71 vaccination program on hand, foot, and mouth disease in Guangdong, China:a longitudinal surveillance study.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00376.
    PubMed         Abstract available

  8. YIN Y, Li X, Qian C, Cheng B, et al
    Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study.
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00374.
    PubMed        


    J Infect Dis

  9. MOODIE Z, Dintwe O, Sawant S, Grove D, et al
    Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.
    J Infect Dis. 2022 Jun 27. pii: 6618597. doi: 10.1093.
    PubMed         Abstract available

  10. AMJADI MF, Adyniec RR, Gupta S, Bashar SJ, et al
    Anti-membrane antibodies persist at least one year and discriminate between past COVID-19 infection and vaccination.
    J Infect Dis. 2022 Jun 27. pii: 6618636. doi: 10.1093.
    PubMed         Abstract available

  11. MOY JN, Anderson M, Shen X, Fu J, et al
    Neutralizing Antibody Activity to SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) After One and Two Doses of BNT162b2 Vaccine in Infection-Naive and Previously-Infected Individuals.
    J Infect Dis. 2022 Jun 27. pii: 6618640. doi: 10.1093.
    PubMed         Abstract available

  12. LLIBRE JM, Revollo B, Aguilar S, Calomarde-Gomez C, et al
    Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19.
    J Infect Dis. 2022 Jun 28. pii: 6619237. doi: 10.1093.
    PubMed        

  13. VENCALEK O, Beran J, Furst T, Kratka Z, et al
    Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2.
    J Infect Dis. 2022 Jun 28. pii: 6619238. doi: 10.1093.
    PubMed        

  14. DEMASO CR, Karwal L, Zahralban-Steele M, Dominguez D, et al
    Specificity and Breadth of the Neutralizing Antibody Response to a Live Attenuated Tetravalent Dengue Vaccine.
    J Infect Dis. 2022 Jun 30. pii: 6623496. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr

  15. CATALDI JR, O'Leary ST, Beaty BL, Hurley LP, et al
    Measles Experience, Practice, and Knowledge by Pediatricians in the Context of Resurgent US Outbreaks.
    J Pediatr. 2022;246:213-219.
    PubMed         Abstract available


    J Virol

  16. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    PubMed        

  17. SHEWARD DJ, Hermanus T, Murrell B, Garrett N, et al
    HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
    J Virol. 2022 Jun 27:e0032422. doi: 10.1128/jvi.00324.
    PubMed         Abstract available


    JAMA

  18. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  19. FLEMING-DUTRA KE, Wallace M, Moulia DL, Twentyman E, et al
    Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:859-868.
    PubMed         Abstract available

  20. DECUIR J, Meng L, Pan Y, Vogt T, et al
    COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:847-851.
    PubMed         Abstract available

  21. MALDEN DE, Hong V, Lewin BJ, Ackerson BK, et al
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:830-833.
    PubMed         Abstract available


    N Engl J Med

  22. ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al
    Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
    N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
    PubMed        

  23. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Effective is Covid-19 Vaccination in Children?
    N Engl J Med. 2022;386:e78.
    PubMed        

  24. LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
    Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
    PubMed        

  25. COHEN-STAVI CJ, Magen O, Barda N, Yaron S, et al
    BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMoa2205011.
    PubMed         Abstract available

  26. TUMMINIA A, Romano M
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2022;387.
    PubMed        

  27. WAXMAN JG, Magen O, Hernan MA
    Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2022;387.
    PubMed        

  28. LARSON HJ, Gakidou E, Murray CJL
    The Vaccine-Hesitant Moment.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMra2106441.
    PubMed        


    Pediatr Infect Dis J

  29. MARSHALL GS, Petigara T, Liu Z, Wolfson L, et al
    Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States.
    Pediatr Infect Dis J. 2022 Jun 24. pii: 00006454-990000000-00113.
    PubMed         Abstract available

  30. YIGIT M, Ince YE, Kalayci F, Santaflioglu B, et al
    The Impact of Childhood and Parental Vaccination on SARS-CoV-2 Infection Rates in Children.
    Pediatr Infect Dis J. 2022 Jun 28. pii: 00006454-990000000-00115.
    PubMed         Abstract available

  31. MALTEZOU HC, Magaziotou I, Tseroni M, Syrigonaki K, et al
    Adherence to Recommendations for Betaacillus Calmette-Guerin Vaccination of High-risk Neonates in Greece.
    Pediatr Infect Dis J. 2022 Jun 22. pii: 00006454-990000000-00110.
    PubMed         Abstract available


    PLoS One

  32. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    PubMed         Abstract available

  33. FERGIE J, Pawaskar M, Veeranki P, Samant S, et al
    Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
    PLoS One. 2022;17:e0269596.
    PubMed         Abstract available

  34. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed         Abstract available

  35. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    PubMed         Abstract available

  36. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    PubMed         Abstract available

  37. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    PubMed         Abstract available

  38. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  39. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    PubMed         Abstract available


    Vaccine

  40. RONZANI P, Panizza F, Martini C, Savadori L, et al
    Countering vaccine hesitancy through medical expert endorsement.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00780.
    PubMed         Abstract available

  41. KOBAYASHI T, Nishina Y, Tomoi H, Harada K, et al
    Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
    Vaccine. 2022 Jun 8. pii: S0264-410X(22)00754.
    PubMed         Abstract available

  42. SOARES GH, Sethi S, Hedges J, Jamieson L, et al
    Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00777.
    PubMed         Abstract available

  43. WANG L, Zhang J, Meng S, Ge L, et al
    Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00784.
    PubMed         Abstract available

  44. HONDA-OKUBO Y, Cartee RT, Thanawastien A, Seung Yang J, et al
    A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00809.
    PubMed         Abstract available

  45. ABRAHAM N, Spruin S, Rossi T, Fireman B, et al
    Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Vaccine. 2022 May 25. pii: S0264-410X(22)00667.
    PubMed         Abstract available

  46. BRAZ HMB, Silva MF, Carvalho TP, Silva LAD, et al
    Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis DeltaabcBA.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00812.
    PubMed         Abstract available

  47. MAERTENS K, Leuridan E, Munoz FM, Zimmermann P, et al
    Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approaches.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00811.
    PubMed        

  48. ZHAO Z, Liao Y, Li Y, Jiang G, et al
    Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00776.
    PubMed         Abstract available

  49. HUANG L, Wasserman M, Grant L, Farkouh R, et al
    Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00773.
    PubMed         Abstract available

  50. LOHMANN S, Albarracin D
    Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
    PubMed         Abstract available

  51. LEAV B, Straus W, White P, Leav A, et al
    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
    Vaccine. 2022 Jun 9. pii: S0264-410X(22)00752.
    PubMed         Abstract available

  52. HU G, Jin WP, Yang ZH, Lv SY, et al
    Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
    Vaccine. 2022 Jun 24. pii: S0264-410X(22)00768.
    PubMed         Abstract available

  53. AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
    A national survey of COVID-19 vaccine acceptance in Nigeria.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
    PubMed         Abstract available


    Virology

  54. LIM H, Kim SE, Lee YH, Hwang YH, et al
    Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.
    Virology. 2022;573:118-123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: